Скачать
The potential of pirtobrutinib in the treatment of CLL
Автор: VJHemOnc – Video Journal of Hematology & HemOnc
Загружено: 2026-03-12
Просмотров: 23
Описание:
Matthew Davids, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the potential of pirtobrutinib, a non-covalent BTK inhibitor, in the treatment of chronic lymphocytic leukemia (CLL), highlighting its efficacy in double-refractory settings and its recent approval in the US as a second-line therapy. This interview took place at the ESH CLL 2026 congress in Stockholm, Sweden.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
